LUCDLucid Diagnostics Inc. Common Stock
0.9643USD-4.52%Mkt Cap: 184.13M $P/E:

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophage…

Key Statistics

Company
Market Cap184.13M $
Enterprise Value173.82M $
Revenue (TTM)5.45M $
Gross Profit-1.96M $
Net Income (TTM)-58.01M $
Revenue/Share0.0390 USD
Last Price0.9643 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees82
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.00
PEG
EV/EBITDA-3.49
EV/Revenue31.92
P/S33.68
P/B16.85
EPS (TTM)-0.39
EPS (Forward)-0.16
52W Range
0.860514% of range1.629
52W High1.629 USD
52W Low0.8605 USD
Profitability
Gross Margin-41.73%
Oper. Margin-868.45%
EBITDA Margin0.00%
Profit Margin-1232.68%
ROE-530.45%
ROA-143.43%
Growth
Revenue Growth26.70%
Earnings Growth
Cash Flow & Leverage
Operating CF-46.48M $
CapEx (TTM)197.00K $
FCF Margin-485.38%
FCF Yield-14.35%
Net Debt-9.56M $
Net Debt/EBITDA0.19
Balance Sheet
Debt/Equity2.36
Current Ratio1.33
Quick Ratio1.29
Book Value/Sh0.0570 USD
Cash/Share0.1810 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.950 USD
Upside (mean)+309.6%
Target Range2.000 USD9.250 USD
$2.000+309.6% to mean$9.250
# Analysts5
Ownership
Shares Out.190.95M
Float140.76M
Insiders26.50%
Institutions33.36%
Short Interest
Short Ratio8.1d
Short % Float7.87%
Short % Out.6.36%
Shares Short12.13M
Short (prev mo.)9.42M
Technical
SMA 500.9903 (-2.6%)
SMA 2001.120 (-13.9%)
Beta1.08
S&P 52W Chg18.16%
Avg Vol (30d)1.32M
Avg Vol (10d)881.65K
Technical Indicators
RSI (14)48.7
MACD-0.0019
MACD Signal-0.0086
MACD Hist.+0.0066
BB Upper1.022 USD
BB Middle0.9501 USD
BB Lower0.8782 USD
BB Width15.13%
ATR (14)0.0557 USD
Vol Ratio (20d)0.39x